|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
9855
|
DOTA-NAPamide trifluoroacetate
|
9855.0001: 1 mg per vial
9855.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for radiolabelled DOTA-NAPamide
|
|
|
|
|
|
|
|
|
Molar Mass: 1485.65
|
|
|
C68H100N20O18
|
|
|
[935886-72-9] (net peptide)
|
|
|
|
|
|
Colourless to off-white freeze-dried solid packaged in screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: ≥ 95 %
|
|
|
Certificates:
CoA; MS (identity); HPLC (purity)
|
|
|
Chemical Name:
Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys(DOTA)-NH2
|
|
|
Synonymes:
[Nle4,Asp5,D-Phe7, Lys11(DOTA)]-α-MSH(4-11); CA index name: L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophylglycyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-
|
|
|
Literature:
Froidevaux S. et al. A Gallium-Labeled DOTA-α-Melanocyte-Stimulating Hormone Analog for PET Imaging of Melanoma Metastases. J. Nucl. Med. 2004, 45, 116-123.
|
|
|
Froidevaux S. et al. Melanoma Targeting with DOTA-α-Melanocyte-Stimulating Hormone Analogs: Structural Parameters Affecting Tumor Uptake and Kidney Uptake. J. Nucl. Med. 2005, 46, 887-895.
|
|
|
Cheng Z. et al. Cu-Labeled α-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression. Bioconjugate Chem. 2007, 18, 765-772.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
10 May 2017
|